FDA Investigator Kimberley A Ricketts

Kimberley A Ricketts has inspections in 2 countries as of 07 Nov 2023. Kimberley A Ricketts has collaborated with a combinined 3322 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
123
Last Inspection Date:
07 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Trinidad and Tobago
Co-Investigator(s):
Ali A Patino, Alia Legaux, Alice S Tsao, Althea A Williams, Amber D Brodas, Amy Kim, Amy S Graf, Amy W Yan Mai, Anastasia M Shields, Andrew F Cohen, Andrew J Garufi, Andrew J Molesky, Angela Jourdain, Ann B Okon, Anthony N Onianwa, Anthony R Rauert, Arduino Frankovic, Armia A Beshay, Ashley Polizzotto, Ayorinde O Babalola, Bernardica T Sculac Stern, Betty M Ng Lee, Brian J Ryan, Cara M Minelli, Carolyn J Cook, Carrie E Jolly, Charisse K Green, Christian Parra, Christine M Rivera, Christopher D Snyder, Christopher S Fields, Cosmon L Barrett, Crystal A Branch, Dana A Razzano, Daniel L Aisen, Dave M Deroche, David A Carlson, David A Laplante, David A Trent Carlson, David J Leray, David R Delucia, Demitria J Xiradakis, Denise L Terzian, Dipesh K Shah, Donald J Ullstrom, Douglas G Ng, Dr. Robert C Horan, MD, Duo D Chen, Elizabeth H Davis, Elizabeth H Slazak, Eric J Reisenauer, Erica B Raphael, Erin L Nagel, Evelyn Taha, Fatima Bassa, Frank Verni, Gam S Zamil, Gayle J Gehrman, Geoffrey K Kilili, George C Amedro, Gray, Gregson A Joseph, Harry J Brewer, Hilary K Wagner, Iram R Hassan, PhD, Irina Gaberman, Jacqueline S Warner, James A Liubicich, James D Bridges, Janaysia N Trail, Jane Chen, Jason Kwong, Jay T Wong, Jeanette L Mcginnis, Jedeon M Virata, Jennifer A Bazergui, Jennifer L Custodio, Jennifer Macmillan, Joanne M Schlossin, Joel R Merriman, John A Podsadowski, John E Aghadia, Jose O Hernandez, Joseph A Dinardo, Joseph A Famiglietti, Joseph Duca, Joseph J Vannelli, Joseph Maselli, Joseph Milcetic, Joy P Matthias, Joyce A Williams, Juan Rjimenez Garcia, Judy Keihl, Juliana Falla, Julie Scoma, Karen L Kosar, Kazi Rafiquzzaman, Kellie Leveille, Kerry D Noto, Kim M Downing, Kimberley A Gordon, Kip J Hanks, Kwong P Lee, L Gnnmassimia Massimilla, PharmD, Lauren E Blaser, LCDR Chad N Thompson, Leena Thomas, Linda M Pyjas, Linda M Sacco, Lisa Mathew, LTJG Matthew R Palo, Marc S Neubauer, Margaret N Klug, Marlene L Davis, Mary M Finn, Mary T Carden, Matthew A Johnson, Matthew D Schnittker, Melina Lrodriguez Upton, Melinee C Minhas, Melissa N Gregorio, Mercedes G Castillo, Meredith P Soehl, Investigator, Michael A Charles, Michael G Mayfield, Michael R Dominick, Michael W Burd, Milan S Kunajukr, Milan S Mcgorty, Morgan J Matthews, Muchael W Burd, Nazmul Hassan, Neil J Bonzagni, PhD MPH, Nicole Vaught, Osama A Khatib, Paul E Stein, Paul M Gelfand, Paul Mouris, Pearl L Gonzalez, Perez, Peter Abel, Peter M Trunk, Peter R Caparelli, Raymond M Lam, Richard K Glabach, Rita F Monfort, Robert C Steyert, Robert E Moncayo, Ronald Ifraimov, Ronald Y Ifraimov, Sarah A Meehan, Sargum C Sood, Satheesh Thomas, Seemay A Lee, Shamel Jaime, Shannon A Dinardo, Shelly A Persaud, Sherrona J Robinson, Shreya Shah, Simone E Pitts, Sonia E Ortiz, Sony Mathews, State Agency, Stephanie T Durso, Sunita Vij, Susan M Jackson, Susant Hadman, Suyang Qin, Taina Pierre Pierre, Tamara M Simpson, Tamil Arasu, PhD, Tammy S Notto, Tara K Carmody, Tara K Normandin, Thomas J Mooney, Thomas L Bellonte, Tracy M Portelli, Uduak M Inokon, Unnee Ranjan, Valerie A Potopsingh, Valerie C Reed, Valerie J Grecek Trinh, Vanessa M Williams, Vincent T Duncan, Wayne J Meyer, Wendy M Stone, William C Lubas, William J Leonard, Willy A Orantes, Winston R Alejo, Yuyan Liang, Yvette Mlacour Davis, Yvonne M Santiago, Zameer Farouk

Kimberley A Ricketts's Documents

Publish Date Document Type Title
January, 2013 FDA 483 Richmond University Medical Center - Form 483, 2013-01-23
October, 2013 FDA 483 Genadyne Biotechnologies, Inc. - Form 483, 2013-10-15
May, 2010 FDA 483 Lornamead - Form 483, 2010-05-07
January, 2013 EIR Richmond University Medical Center - EIR, 2013-01-23
September, 2010 EIR Azteca Linda Corp. - EIR, 2010-09-03
February, 2012 FDA 483 Mick Radio Nuclear Instr Inc - Form 483, 2012-02-22

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.


Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more